SCIENTIFIC POSTERS SESSIONS

Author

Organization or Academic Institution

Poster Title

Thomas Chamberlain

Acuitas Therapeutics

Identification Of Novel Lipids with Improved Activity For Prophylactic Vaccine Development

Kazuya Kominami

Hisamitsu Pharmaceuticals

HalDisc®: A Fast and Reliable Novel Device for Vaccination

Craig Laferriere

iosBio Ltd.

Oral Vaccine against Epstein-Barr Virus: Systemic and Mucosal Immunity for Prevention of Infection

Walid Abdelwahab

University of Montana

Advancing UM-1098: A Novel Synthetic Th17-Inducing Mincle-Based Adjuvant Formulation

Yang XU

Luna Labs USA

NanoVac Enabled Delivery of Glycoproteins and mRNA for HIV-1 Vaccine

Louay Bachnak

Tulane University School of Medicine

Novel combination adjuvanted parenteral vaccine protects against influenza infection

Maksim Mezhericher

Inaedis, Inc.

Room Temperature Aerosol Dehydration for Thermostable Powdered Vaccine Formulations

Carolina Stephenson

MilliporeSigma

Tailored Cell Culture Media Solutions for Vaccine Production: Boosting Cell Growth and Virus Titers

Xiaoyu Zhang

Agilent

Real-Time Cellular Impedance Technology for Determining Viral and Antibody Titers, and For Evaluating Antiviral Drugs

Dr. -Ing. Yeonhwa Jin

Sartorius stedim biotech GmbH

Next-Generation Influenza Vaccine Production: Advancing Scalability with the 4Cell® MDCK Suspension Platform

Charles Williams

LenioBio

Pandemic Preparedness with ALiCE® - Scalable eukaryotic cell-free protein synthesis enables ultra-rapid threat response

Richard R Matner, PhD MBA

PlantPharm BioMed

Vaccine Production in Plants - Mucosal (oral) Induced Immunity

Lirong Cao

The Chinese University of Hong Kong

Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance

Maggie Haitian Wang

The Chinese University of Hong Kong

Predicting seasonal influenza virus evolution considering site-based mutation dynamics

Kelem Chagas

ICON

Clinical trials in the vaccine space after the COVID 19 pandemic - CRO perspective

Junlan Ren

Henovcom Bioscience

Polyvalent mRNA vaccine with high-efficiency LZCap® and novel ionizable lipid elicited robust and long-lasting humoral and cellular immune responses

Juliana Taube

Georgetown University

The global landscape of smallpox vaccination history and implications for current and future orthopoxvirus susceptibility: a modelling study

Jhishnuraj Kannan

University of Illinois Chicago

Vaccine efficacy of a cGMP-manufactured rBmHAXT(∆cys), a tetravalent fusion protein vaccine for human Lymphatic Filariasis

Rodrigo Jorge de Bessa Abreu

LifeArc

Driving affordable access for biologics against infectious diseases.

Julie LaValley

Dyadic International, Inc.

DEVELOPMENT OF THE C1 TECHNOLOGY FOR THE PRODUCTION OF PROPHYLACTIC MABS AND VACCINES

Maggie N Luce

MilliporeSigma

Applying Next Generation Sequencing to Test Raw Materials used in Biologics Manufacturing

Rebecca Bova

MilliporeSigma

Regulatory updates for the use of Next Generation Sequencing for Adventitious Virus Detection

Elodie Burlet

VaxForm

A novel delivery system to enhance the immune response and shelf-life stability of mRNA vaccines

Jennifer Grossman

Walter Reed Army Institute of Research

Full Spectrum Biomanufacturing Support for Phase I at WRAIR's Pilot Bioproduction Facility

Patrick Thiaville

4basebio

Harnessing synthetic DNA for scalable mRNA and DNA vaccine manufacture

TAE GI UHM

ST Pharm, Biotechnology Research & Development, Biotech CDMO2

Accelerating Cost-Efficient xRNA Therapeutics Research with Noble Ionizable Lipid (STLNP®) and Capping Reagent (SmartCap®) Technologies

Gopal B. Krishnan

Promega Corporation

Cell-Based Reporter Bioassays Enable Precise Quantification of ADCC and Neutralizing Antibody Responses for Vaccine Immunogenicity Testing

Jonathan Mitchell

Promega Corporation

Cell-based Bioassay Platform for Safe, Rapid Quantitation of Virus Neutralization and Antibody-Dependent Enhancement

Jeremiah Kim

Signl

High Throughput Screening of Immunomodulators for Vaccine Adjuvants and Beyond

Valerie Duval

Combined Therapeutics

The next generation of adjuvanted mRNA-based vaccines to prevent infectious diseases with controlled biodistribution and long-lasting immunogenicity

Taro Saito

Canon Medical Diagnostics Corporation

Monitoring of acquired immunity after COVID-19 mRNA vaccination using ex vivo cellular immunoassay by gene detection (EAGL) assay and estimation of vaccine effect

Kailee Popowich

VIDO

Developing a Pseudovirus Library of Zoonotic Coronavirus Spike Proteins

Irnela Bajrovic

Jurata Thin Film

Revolutionizing Formulation Development: Stabilization of Various API

Hernan Hermes Monteiro da Costa

Adolfo Lutz Institute; Icahn School of Medicine at Mount Sinai

Identification of a phage-display derived anti-SARS-CoV-2 fusion peptide monoclonal antibody from vaccinated and infected donors

Joshua McGee

Keylicon Biosciences

Optimizing the chemistry and sequence of self-amplifying RNAs to suppress inflammatory responses and improve the potency of RNA vaccines

Tesfaye Tsigu De

UNICEF

The Effect of Solar Direct Derive Cold Chain Equipment on the Performance of Immunization Services in Health Facilities of Ethiopia

Barbara Cornelissen

Exothera

Advancing mRNA Manufacturing and Characterization: Comprehensive Analytical Capabilities for mRNA Therapeutics

Dinja Oosterhoff

CeraVx

Ceramic Microneedle Array Patches for Intradermal Delivery of Vaccines

Chiang-Yun Chen

CHO PHARMA INC.

Conjugate Vaccine Development against Klebsiella pneumoniae

Adthakorn Madapong

Nebraska Center for Virology

Immunity and Protective Efficacy of a Plant-based Tobacco Mosaic Virus-Like Nanoparticle Vaccine Against Influenza A Virus in Mice

Ian villamagna

Sartorius

LipidBrick®: Cationic Lipid Library Enables Next-Generation LNP Formulations for Improved Efficacy, Specific Targeting and Safety of RNA Vaccines​

Sreejit Menon

Croda Inc

VirodexTM TXR-1 and TXR-2, a sustainable compendial grade cGMP detergent substitute for TritonTM X-100 in bioprocessing applications in various applications in the vaccine field.

Myriam K

Areterna

VZV Vaccine with CAP5011 Showed Stronger Immune Response in Mice

GARIMA SINHA

Croda Inc.

The impact of Poloxamer 188 quality on cell health for the improvement of vaccine manufacturing

suhyeon Kim

Plumbline

mRNA vaccine for SARS-CoV2

Jeonghun Kim

Progeneer

Novel TLR7/8 Agonist Adjuvant Platform: ProLNG, Providing Tailored Solutions For Vaccine Needs

Justin Goodarz

Verified Clinical Trials

Preventing (vs Detecting) Duplicate & Professional Participant Enrollment within Vaccine Clinical Trials - A Quality by Design Initiative

Annie

Yeasen Biotechnology (Shanghai) Co.,Ltd.

The rise of mRNA therapeutics

Di Bai

University of Alabama at Birmingham

Development of Semi-Synthetic Saponin Vaccine Adjuvants

Jorge Armero Gimenez

LenioBio

Rapid screening and scaled manufacture of immunogenic virus-like particles in the ALiCE cell-free protein synthesis system

Matt Kremer

Univercells Technologies (a Donaldson company)

Continuous Product Improvement to Provide a Whole Product Solution for Viral Vaccine Manufacturing

Annie Chang

Yeasen Biotechnology (Shanghai) Co.,Ltd.

The rise of mRNA therapeutics

Mary Retzlaff

Ambient Biosciences

Characterization and Immunogenicity of Vaccines Stabilized by Capillary Assisted Vitrification- A Novel Approach to Vaccine Formulation

Kathy Le

uBriGene Biosciences Inc.

Quality Control Methods for Circular RNA Purity and Integrity: SEC-HPLC, CE, and RP-HPLC

Samin Akbari

Sartrorius

Advancing RNA Therapeutics with Novel RNA/LNP screening and manufacturing platforms

Dr Ilona Baraniak-Lang

Cencora, PharmaLex GmbH

The Complex Regulatory Landscape for Personalized Cancer Vaccines- A case study of a Parallel Development of Personalised Cancer Vaccine in the EU and US

Yuzhong Liu

The Scripps Research Institute

Complete biosynthesis of QS-21 in engineered yeast

Christina Go

Integral Molecular

Tools for analyzing the immune response to virus infection and vaccines

Christina Go

Integral Molecular

Flavivirus Reporter Particles for Vaccine Research

Assoc. Prof. Waranyoo Phoolcharoen

Baiya Phytopharm Co., Ltd

Next-Generation Monoclonal Antibodies: Prolonged Half-Life & Blood-Brain Barrier Penetration for Transformative Therapeutics

Hans Hutting

Kerry

High Salt, High Impact: An Endonuclease Engineered for High-Efficiency DNA Removal in Viral Vector Manufacturing

Roberto Carlos Vieira da Silva Júnior

FCF - USP / UNIVERSIDADE DE SÃO PAULO

Development of a Computational System Using Artificial Intelligence for Vaccine and Chimeric Protein Production: From In Silico to In Vivo

James Allen

Cleveland Clinic

Design and characterization of H3 COBRA antigens in pre-immune mice and ferrets

Andrew Tsao

GenScript USA Inc

Overcoming Challenges in mRNA Plasmid Preparation: Advanced Solutions for Poly(A) Tail Integrity and High-Yield Production

Kate Scott

Apiject Systems

Life Cycle Assessment (LCA) and Comparison of Five Sterile Injectable Platforms

Chris Buck

National Cancer Institute

How to Make and Share Vaccine-Style Beer

Sunil Thomas

Lankenau Institute for Medical Research

CHARTING THE MAJOR PROTEINS OF OROPOUCHE VIRUS

Ciara M Weets

Georgetown University Center for Global Health Science and Security

Strengthening Health Security Through Routine Vaccination Policy: A Comprehensive Analysis of Childhood Vaccination Laws Across 194 Countries

Fadil Bidmos

Imperial College London

Precision immunology driving innovation in next-generation bacterial vaccine development

Gillot

UNamur

Evolution of Neutralizing Antibody Titers Against RSV in a Cohort of Infected Patients: A Longitudinal Study

Young June Choe

Korea University College of Medicine

Preconception and Early Pregnancy COVID-19 Vaccination: Impact on Infection and Pregnancy Outcomes in a National Korean Cohort

Manuji Bandara

University of Ruhuna

Efficacy, Safety, and Immunogenicity of mRNA-1345 for Respiratory Syncytial Virus Prevention in Adults: A Systematic Review

Onuoha ThankGod

Novena University, Ogume

Prevalence of Mycobacterium Tuberculosis Amongst Tobacco Smokers in Selected Communities in Ndokwa

Joshua Wiggins

University of Nebraska - Lincoln

Strategic Adenoviral-Vectored Vacines for Ebola

ACCORNERO

BIOASTER

Exfoliome, a proxy of the gut mucosal immune response

Micha ROUMIANTZEFF

MICHADVICES

50/100 Million Unvaccinated Children in the World

Reagan Rodriguez

Purilogics by Donaldson

Membrane-based Chromatography Solution for Nucleic Acid Purification

Antonio Pisani

Boston University Chobanian & Avedisian School of Medicine

Examining Parent, Child, and Provider Experiences with Early Childhood Immunization for an HPV Vaccine Trial Among Four to Eight-Year-Olds: A Mixed Methods Study

Wayne Collins

Ovagen Group Limited

Microbiological Assessment and Evaluation of Virus Yield in Germ-free Chicken Eggs

Daniel Thoresen, Kenta Matsuda, Summer Acevedo, Jonathan Smith, Wataru Akahata

VLP Therapeutics Inc.

A Tetravalent Dengue VLP Vaccine Produces a Durable and Balanced Immune Response

Elizabeth Peters*, Masayuki Aboshi, Daisuke Kawakami, Kaoru Kono, Ayae Nishiyama, Takuto Nogimori, Yuko Sunada, Kenta Matsuda, Takashi Sekida, Shigeru Suga, Jonathan F. Smith, Nobuaki Sato, Takuya Yamamoto, and Wataru Akahata

VLP Therapeutics Inc.

A Phase 2 Study of VLPCOV-02, a SARS-CoV-2 Self-amplifying RNA Vaccine with the modified base 5-methylcytosine, shows an improved safety profile without compromising immunogenicity.

Nejc Pavlin, Mojca Bavčar, Tristan Kovačič, Tjaša Plesničar, Andreja Gramc Livk, Aleš Štrancar

Sartorius

A Chromatographic Tool to Comprehensively Characterize Complex Novel RNA-LNP Drug Products.

Isabella Impalli

One Health Trust

Potential Economic Impact of a Maternal Klebsiella pneumoniae Vaccine in 107 Low- and Middle-Income Countries.

Ajeet Kumar Singh

Immunization Technical Support Unit, Ministry of Health and Family Welfare, Government of India

Impact of Rotavirus Vaccine on Malnutrition among Children: Evidence from National Family Health Survey (NFHS) 2019-2021, India

Kate Gilbert

Brown University

A Novel Glycoconjugate Architecture to Probe Spatial Determinants of B cell Activation for PilE Glycan Antigens of multidrug resistant Neisseria gonorrhoeae

Jamison Grailer

Promega Corp

Development of a Novel Luminescent Assay for Sensitive and Specific Quantitation of Double-Stranded RNA

Carolin Golibrzuch

Millipore Sigma (Merck KGaA Germany)

Pioneering a New Era in Purification for Gene Therapies and Advanced Drug Delivery through the Nanofitin® Affinity Technology

William Rushton

Bio-Rad Laboratories

Optimizing Viral Vector Purification: Enhancing Yield and Purity with a Weak AEX-HIC Chromatography Resin

Girma Birhanu Nurie

Addis Ababa City Administration Health Bureau Dept of Public Health Emergency Management

OUTBREAK INVESTIGATION OF SUSPECTED ACUTE WATERY DIARRHEA (AWD), WOGERA DISTRICT, NORTH GONDAR ZONE, AMHARA, ETHIOPIA, OCTOBER 2017

Sucheta Rajaraman

University of Illinois, Chicago. College of Medicine, Rockford

Vaccine potential of a tetravalent recombinant fusion protein antigen of Dirofilaria immitis against the heartworm infection.

Ananya Aggarwal

University of Illinois, Chicago. College of Medicine, Rockford

Bridging Studies to Evaluate the cGMP-Manufactured, rBmHAXT (∆cys) Vaccine Against Lymphatic Filariasis in a Jird Model

Carla Rodriguez Watson

Reagan-Udall Foundation for the FDA

Empowering educators to teach about vaccine science in middle school: Insights from North Carolina educators about free teaching resources

Marie-Louise Lunn

Novo Nordisk Phamatech

TrypsiNNex® enhances the efficiency of cell culture-based influenza virus production

Ghania Chikh

Acuitas Therapeutics Inc.

LNP Development for mRNA Cancer Immunotherapy

Marc Mansour

Virometix AG

V-212, a novel peptide-based, serotype-independent vaccine candidate against Streptococcus pneumoniae

Rebecca Winfree

ViQi Inc.

AVIA: a rapid and scalable cloud-based infectivity assay for vaccine and antiviral screening

Abhishek Chanda

Oregon State University

Bridging Gaps in Antibody Responses and Animal Welfare: Assessing Blood Collection Methods and Vaginal Immunity in Mice Immunized with Intranasal Gonococcal Vaccines

Hazel Clothier

Murdoch Children's Research Institute

Integrated contemporary vaccine safety surveillance delivering real-world evidence

Katy Stein

Microbiologics

Expanding Influenza Assay Capabilities to Support Vaccine Development

Sandra Halverson

FHI Clinical

Accelerating Innovation: Navigating Regulatory Pathways for Cancer Vaccines

Andrew Jurgensen

Accelerated Enrollment Solutions (AES)

Participant Recruitment in the Evolving Age of Vaccine Hesitancy

Haj Shirley

Vaccine Equity Education Coalition (VEEC)

Empowering Peer Facilitators to Advance Vaccine Confidence: A Community-Centered Model from the Vaccine Equity Education Coalition (VEEC)

SOAZIC ELISE WANG SONNE

The World Bank Group

Reaching zero-dose children in Angola: the cost of inaction

SOAZIC ELISE WANG SONNE

The World Bank Group

Fiscal Space Options for Sustainable Immunization Financing in GAVI's Accelerated Transition Phase Countries: Evidence from the Republic of Congo and Sao Tome and Principe

Jonathan Dodd

Revvity (Certimmune)

Impact of PBMC stabilisation reagents on the use of aged blood in Fluorospot & flow cytometric platforms

Jonathan Lecocq

Quantoom Biosciences SA

Quantoom is powering RNA innovation with N-Force

Mansab Ali Saleemi

Oregon State University

Gold Nanoparticles Conjugated with Adenosine Triphosphate for Enhanced Antibacterial Activity Against Neisseria gonorrhoeae and Neisseria meningitidis

Josephine Hammerlindl

Navigo Proteins GmbH

Overcoming challenges in Ferritin extraction from blood plasma: precise affinity chromatography solutions

Clara J Sei

Longhorn Vaccines and Diagnostics, LLC

A Broad-Based Composite Peptide Vaccine Targeting Conserved Bacterial Cell Wall and Toxin Epitopes: Towards the Prevention of Sepsis and Inflammation

Jim Chen

Innorna Co., Ltd.

From Bench to Bedside: Harnessing Innorna’s End-to-end mRNA-LNP Development Platform

Elle Li

Innorna Co., Ltd.

Optimized Vaccine LNP with Favorable Tissue Distribution and Safety Profiles to Accelerate the Prevention of Infectious Diseases

Grzegorz Preibisch

Deepflare

Reliable in silico T cell activation prediction for neoantigens close to self-peptidome

Adelle Keys

Cytiva

Optimized and scalable LNP composition for RNA vaccine delivery

Laurent BELOEIL

BIOASTER

A predictive signature of vaccine reactogenicity from human peripheral blood to benchmark novel vaccine formulations

Maria Laura Dona Mourao

Beth Israel Deaconess Medical Center

Neonatal Vaccination: A Ten-Year Retrospective Study in a Large Delivery Center

Victor Bronshtein

VitriRad

Thermostable Radiation Inactivated Vaccines

Laura Ahlers

Meso Scale Discovery

Detection of Influenza A Nucleoprotein Antigen and H5-specific Antibodies in Dairy Cow Milk Samples

Sourav Singha Roy, Kajal Arora, Ankita Rani, Shalini, M.Deepika,Nupur Mehrotra, Prabuddha K. Kundu

Premas Biotech

Two arms of vaccine: VLP & VLPcRNA complex ensuring the thermostability and pandemic preparedness